The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard Grube, MD, Ulrich Gerckens, MD, Raimund Erbel, MD, Holger Eggebrecht, MD, Ralf Zahn, MD, Axel Linke, MD, Horst Sievert, MD, Hans-Reiner Figulla, MD, Karl-Heinz Kuck, MD, Karl Eugen Hauptmann, MD, Ellen Hoffmann, MD, Rainer Hambrecht, MD, Gert Richardt, MD, Stefan Sack, MD, Jochen Senges, MD, Georg Nickenig, MD, Nikos Werner, MD American Heart Journal Volume 164, Issue 1, Pages 102-110.e1 (July 2012) DOI: 10.1016/j.ahj.2012.04.016 Copyright © 2012 Mosby, Inc. Terms and Conditions
Figure 1 Access site and associated prevalence of PAD in the German TAVI Registry. American Heart Journal 2012 164, 102-110.e1DOI: (10.1016/j.ahj.2012.04.016) Copyright © 2012 Mosby, Inc. Terms and Conditions
Figure 2 Clinical outcomes. Clinical outcomes according to prevalence of PAD. American Heart Journal 2012 164, 102-110.e1DOI: (10.1016/j.ahj.2012.04.016) Copyright © 2012 Mosby, Inc. Terms and Conditions
Figure 3 In-hospital mortality and logistic EuroSCORE. In-hospital mortality (colored bars) and mean logistic EuroSCORE (gray bars) according to access site and prevalence of PAD. American Heart Journal 2012 164, 102-110.e1DOI: (10.1016/j.ahj.2012.04.016) Copyright © 2012 Mosby, Inc. Terms and Conditions
Figure 4 Kaplan-Meier estimates of 30-day mortality. Kaplan-Meier estimates of 30-day mortality according to access site and prevalence of PAD. American Heart Journal 2012 164, 102-110.e1DOI: (10.1016/j.ahj.2012.04.016) Copyright © 2012 Mosby, Inc. Terms and Conditions